News
Important Only
Exxon says it is confident it will win dispute over Chevron-Hess deal
HOUSTON, May 29 (Reuters) - The arbitration proceedings in Exxon Mobil's XOM.N contractual dispute over Chevron's CVX.N planned acquisition of Hess HES.N concluded this week and a decision is expected in about two to three months, said Exxon senior vice president Neil Chapman on Thursday.Whi...Reuters
Thu, May 29
WH Economic Adviser Hassett: Confident in success of tariff ruling appeal
In an interview with Fox Business Network on Thursday, Kevin Hassett, Director of the United States (US) National Economic Council (NEC), said that he is confident in the success of the tariff ruling appeal, per Reuters.Fxstreet
Thu, May 29
US signals it may use administrative process against Harvard
May 29 (Reuters) - The Trump administration signaled on Thursday it might back off plans to immediately revoke Harvard University's ability to enroll foreign students because of several concerns, including its alleged failure to police antisemitism on campus, and would instead employ a lengthier...Reuters
Thu, May 29
CIBC Executive Says Lower Delinquency Rate In Q2 Gives Comfort
May 29 (Reuters) - Canadian Imperial Bank of Commerce CM.TO:CIBC EXEC SAYS LOWER DELINQUENCY RATE IN Q2 GIVES COMFORT: CONF CALLCIBC EXEC SAYS MORTGAGE BUSINESS IS A MUCH SMALLER CONTRIBUTOR; NUMBER OF SINGLE PRODUCT MORTGAGE CLIENTS IS COMING DOWNReuters
Thu, May 29
Cocrystal Pharma’s CC-42344 Shows Strong Antiviral Potency Against 2024 H5n1 Avian Influenza Strain
May 29 (Reuters) - Cocrystal Pharma Inc COCP.O:COCRYSTAL PHARMA’S INVESTIGATIONAL DRUG CANDIDATE CC-42344 DEMONSTRATES STRONG ANTIVIRAL POTENCY AGAINST THE 2024 HIGHLY PATHOGENIC H5N1 AVIAN INFLUENZA STRAINReuters
Thu, May 29
Alzamend Neuro Announces Dosing Of First Patient In Phase II Clinical Trial Of Al001 “Lithium In Brain” Study
May 29 (Reuters) - Alzamend Neuro Inc ALZN.O:ALZAMEND NEURO ANNOUNCES DOSING OF FIRST PATIENT IN ITS PHASE II CLINICAL TRIAL OF AL001 “LITHIUM IN BRAIN” STUDY TAKING PLACE AT MASSACHUSETTS GENERAL HOSPITALALZAMEND NEURO INC - TOPLINE DATA EXPECTED BY YEAR ENDReuters
Thu, May 29
Gaza aid system under pressure as thousands seek food
Chaotic scenes as new US-backed group starts operationsMany forced to walk long distances for foodIsraeli strikes kill 45 peopleBy Nidal al-Mughrabi CAIRO, May 29 (Reuters) - After a slow and chaotic start to the new U.S.-backed aid system in Gaza, thousands of Palestinians have been arriving at ...Reuters
Thu, May 29
BRP's President And CEO, José Boisjoli, To Retire By The End Of The Fiscal Year
May 29 (Reuters) - BRP Inc DOO.TO:BRP'S PRESIDENT AND CEO, JOSÉ BOISJOLI, TO RETIRE BY THE END OF THE FISCAL YEAR AFTER 22 YEARS AT THE HELM OF THE CORPORATIONBRP INC - JOSÉ BOISJOLI TO STEP DOWN AS CHAIR OF BRP BOARDReuters
Thu, May 29
Hormel Foods Corp - Q2 Net Sales $2.90 Billion - SEC Filing
May 29 (Reuters) - Hormel Foods Corp HRL.N:Q2 NET SALES $2.90 BILLION - SEC FILINGQ2 ADJUSTED EPS $0.35 - SEC FILINGNARROWS FY ADJUSTED DILUTED EPS EXPECTATIONS TO $1.58-$1.68 - SEC FILINGOUTLOOK FY NET SALES $12.0 - $12.2 BILLIONQ2 EARNINGS PER SHARE VIEW $0.34, REVENUE VIEW $2.91 BILLION -- LSEG I...Reuters
Thu, May 29
Horizon Space Acquisition I Corp - Deadline For Initial Business Combination Extended To June 27, 2025 - SEC Filing
May 29 (Reuters) - Horizon Space Acquisition I Corp HSPO.O:HORIZON SPACE ACQUISITION I CORP - DEADLINE FOR INITIAL BUSINESS COMBINATION EXTENDED TO JUNE 27, 2025 - SEC FILINGHORIZON SPACE ACQUISITION I CORP - MAY EXTEND BUSINESS COMBINATION DEADLINE TO DECEMBER 27, 2025 - SEC FILINGSource text: [ID:...Reuters
Thu, May 29
